Stockreport

RenovoRx Inc (RNXT) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... [Yahoo! Finance]

RenovoRx, Inc.  (RNXT) 
PDF Gross Profit for Q4 2025: Gross Margin for Q4 2025: Research and Development Expenses for Q4 2025: $1.5 million. Research and Development Expenses for Full-Year 2 [Read more]